Performance of the Procleix SARS-CoV-2 transcriptase-mediated amplification (TMA) assay for the diagnosis of COVID-19 in nasopharyngeal sample pools. Small pilot study
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 35(2022), 1 vom: 21. Feb., Seite 103-104 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Rendimiento del ensayo de amplificación mediada por transcriptasa (TMA) Procleix SARS-CoV-2 para el diagnóstico de COVID-19 en “pools” de muestras nasofaríngeas. Pequeño estudio piloto |
|---|
| Beteiligte Personen: |
Pérez-Abeledo, M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
DNA-Directed RNA Polymerases |
|---|
| Anmerkungen: |
Date Completed 31.01.2022 Date Revised 31.05.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.37201/req/101.2021 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334893682 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334893682 | ||
| 003 | DE-627 | ||
| 005 | 20231225224657.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.37201/req/101.2021 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1116.xml |
| 035 | |a (DE-627)NLM334893682 | ||
| 035 | |a (NLM)34953472 | ||
| 035 | |a (PII)sanz26dec2021 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Pérez-Abeledo, M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Performance of the Procleix SARS-CoV-2 transcriptase-mediated amplification (TMA) assay for the diagnosis of COVID-19 in nasopharyngeal sample pools. Small pilot study |
| 246 | 3 | 3 | |a Rendimiento del ensayo de amplificación mediada por transcriptasa (TMA) Procleix SARS-CoV-2 para el diagnóstico de COVID-19 en “pools” de muestras nasofaríngeas. Pequeño estudio piloto |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.01.2022 | ||
| 500 | |a Date Revised 31.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a pooling samples | |
| 650 | 4 | |a transcriptase mediated amplification | |
| 650 | 7 | |a RNA, Viral |2 NLM | |
| 650 | 7 | |a DNA-Directed RNA Polymerases |2 NLM | |
| 650 | 7 | |a EC 2.7.7.6 |2 NLM | |
| 700 | 1 | |a Ramos, B |e verfasserin |4 aut | |
| 700 | 1 | |a Candel, F J |e verfasserin |4 aut | |
| 700 | 1 | |a Sanz, J C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia |d 1997 |g 35(2022), 1 vom: 21. Feb., Seite 103-104 |w (DE-627)NLM090649028 |x 1988-9518 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2022 |g number:1 |g day:21 |g month:02 |g pages:103-104 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.37201/req/101.2021 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2022 |e 1 |b 21 |c 02 |h 103-104 | ||